Individualised treatment of proliferative diabetic retinopathy: Optimal surgical timing improves long-term outcomes

EPMA Journal

Volumn 1, Issue 1, 2010, Pages 78-81

  Zenoni, Stefano ^a   Comi, Natalia ^a   Fontana, Piero ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Improved outcomes; Individualised treatment algorithms; Proliferative diabetic retinopathy; Targeted preventive measures

Indexed keywords

PROTEIN KINASE C INHIBITOR; TRIAMCINOLONE ACETONIDE; VASCULAR TARGETING AGENT; VASCULOTROPIN INHIBITOR;

ARTICLE; BLOOD RETINA BARRIER; CATARACT; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; ENDOPHTHALMITIS; EYE CARE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRIS RUBEOSIS; LASER COAGULATION; LONG TERM CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; POSTOPERATIVE COMPLICATION; PREVENTION STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA MACULA HEMORRHAGE; TREATMENT INDICATION; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 79953038527     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1007/s13167-010-0007-4     Document Type: Article

References (18)

1. Fong DS, Aiello LP, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care. 2004;27(suppl):84S-87S.
2. Yam J, Kwok A. Update on the treatment of diabetic retinopathy. Hong Kong Med J. 2007;13(1):46-58.
3. The diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
4. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
5. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61:1086-1097.
6. Gupta A, Gupta V, Thapar S, Bhansali A. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol. 2001;37:675-682.
7. Sen K, Misra A, Kumar A, Pandey RM. Simvastatin retards progression of retinopathy in diabetic patients with hypercholestrerolemia. Diabetes Res Clin Pract. 2002;56:1-11.
8. PKC-DRS2 Group, Aiello LP, Davies MD, Girach A, et al. Effect of ruboxistaurin on visul loss in patients with diabetic retinopathy. Ophthalmology. 2006;113:2221-2230.
9. Zein WM, Noureddin BN, Jurdi FA, Schakal A, Bashshur ZF. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the treatment of proliferative diabetic retinopathy with macular edema. Retina. 2006;26:137-142.
10. Bandello F, Polito A, Pognuz DR, Monaco P, Dimastrogiovanni A, Paissios J. Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy. Arch Ophthalmol. 2006;124:643-650.
11. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. 2006;113(1695):e1-15.
12. Chen E, Park CH. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina. 2006;26:699-700.
13. Ho T, Smiddy WE, Flynn Jr HW. Vitrectomy in the management of diabetic eye disease. Surv Ophthalmol. 1992;37 (3):190-202.
14. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial. Arch Ophthalmol. 1990;108:958-964.
15. Li X, Jiang Y, Ye C, Li C. Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus. Zhonghua Yan Ke Za Zhi. 1999;35(2):116-118.
16. de Bustros S, Thompson JT, Michels RG, Rice TA. Vitrectomy for progressive diabetic retinopathy. Arch Ophthalmol. 1987;105:196-199.
17. O'Hanley GP, Canny CL. Diabetic dense premacular hemorrhage. A possible indication for prompt vitrectomy. Ophthalmology. 1985;94(4):507-511.
18. Ramsay RC, Knobloch WH, Cantrill HL. Timing of vitrectomy for active proliferative diabetic retinopathy. Ophthalmology. 1986;93(3):283-29.